Cornerstone Therapeutics, Inc. (CRTX) Tops Q3 EPS by 19c, Sales Beat
Tweet Send to a Friend
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 EPS of $0.46, $0.19 better than the analyst estimate of $0.27. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
